Safety and Feasibility of Early Laparoscopic Cholecystectomy in High-Risk Acute Cholecystitis: A Critical Evaluation of Tokyo Guidelines 2018 Risk Stratification.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42112895.
- Also identified by DOI 10.1002/wjs.70416.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study evaluated the safety and appropriateness of early laparoscopic cholecystectomy (LapC) for acute cholecystitis classified as high-risk according to the Tokyo Guidelines 2018 (TG18). We retrospectively analyzed 126 patients who underwent early LapC between January 2023 and August 2024. Patients were classified into high-risk (n = 67) and low-risk (n = 59) groups based on TG18 criteria. Primary endpoints were in-hospital mortality and major complications (Clavien-Dindo ≥ IIIa). No in-hospital mortality occurred. Major complications were observed in seven patients (5.6%) with no significant difference between groups (6.0% vs. 5.1%, p = 0.467). Grade 3 cholecystitis was independently associated with overall complications (adjusted OR 3.12, 95% CI 1.03-21.47, p = 0.046). Among Grade 1-2 cases, neither age-adjusted Charlson Comorbidity Index (AA-CCI) nor American Society of Anesthesiologists Physical Status (ASA-PS) correlated with complications, whereas higher preoperative C-reactive protein was an independent predictor (adjusted OR 1.05, 95% CI 1.00-1.10, p = 0.037). In our single-center experience, early LapC was safely performed in TG18-defined high-risk patients with Grade 1-2 cholecystitis. Traditional static risk indicators (AA-CCI, ASA-PS) showed limited predictive value in our cohort, whereas dynamic inflammatory markers such as CRP showed potential for risk assessment, though further validation is needed.